Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-12-22

FDA Approved: PREZISTA — Supplemental Application (Janssen Products LP)

View source ↗

Summary

FDA approved a supplemental application for Prezista (darunavir) submitted by Janssen Products LP.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PREZISTA (darunavir)

Snippet

SUPPL AP for PREZISTA (DARUNAVIR)